Beware! Highly ambitious forward EBITDA, page-5

From my understanding the uplift in revenue is based on their acquisition model of buying earnings accretive practices rather than by organic growth which has been pegged at single digits. Synstrat is a business broker for Dental Clinics so have no doubt that it has a biased lean. What is important here is whether they can meet and potentially exceed prospectus. The majority of Morgans floats are set with reasonably low hurdles that can be bettered to provide market momentum.